• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.53% Nasdaq Up0.65%

    Raptor Pharmaceuticals Corp. (RPTP)

    -NasdaqGM
    15.70 Up 0.28(1.79%) 9:38AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 69,497   16,872   -  
    Cost of Revenue9,416  1,653   -  
    Gross Profit 60,081   15,219   -  
    Operating Expenses
    Research Development43,477  29,177  8,963  
    Selling General and Administrative56,654  37,948  8,971  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (40,050) (51,906) (17,934)
    Income from Continuing Operations
    Total Other Income/Expenses Net1,535  (10,679)(1,275)
    Earnings Before Interest And Taxes(38,515)(62,585)(19,209)
    Interest Expense13,971  6,832  83  
    Income Before Tax(52,486)(69,417)(19,292)
    Income Tax Expense54   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(52,540)(69,417)(19,292)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (52,540) (69,417) (19,292)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (52,540) (69,417) (19,292)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.